🇺🇸 FDA
Patent

US 7834037

5-lipoxygenase-activating protein (FLAP) inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7834037 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by AMIRA PHARMACEUTICALS, INC. expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/06, A61P11/00